IE618 Company Profile Presentation Bayer Schering (Germany)caudill/Bayer.pdf · Arne Stöcker Denis Stoimenov Joachim Hacke Waldemar Seel Wan Mohd Norudin IE618 Company Profile Presentation

Arne Stöcker

Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin

IE618

Company Profile Presentation

Bayer Schering (Germany)

Arne Stoecker

02/16/2011

Source: www.bayerscheringpharma.de

Arne Stöcker


Outline

1. Introduction and history

2. Financial summary

3. Scope of products

4. Cost and business issues

Arne Stöcker


Name and corporate type

• Bayer Schering Pharma AG

• “Aktiengesellschaft“ = Corporation

– Since September 2008 not listed anymore

– Subsidiary of Bayer AG

• Pharmaceutical company

• Headquarter: Berlin, Germany

Introduction and History

Arne Stöcker


Background

• 1851

– Ernst Schering purchased chemist´s shop

• 1863

– Friedrich Bayer establishes a dyestuff factory

• 1897

– Bayer develops the active ingredients of aspirin


Arne Stöcker


Background

• 2000

– Schering AG was listed on the NYC stock exchange

• 2002

– Bayer AG was listed on the NYC stock exchange

• 2003

– Bayer Healthcare is established as independent legal entity

• 2006

– Merger of Schering AG and Bayer AG

• 2007

– Bayer Schering operates as a division of Bayer Healthcare

subgroup


Arne Stöcker


StructureBayer AG

Subgroups

Bayer MaterialScience

Bayer CropScience

Bayer HealthCare

Bayer Schering Pharma AG

Animal Health

Consumer Care

Medical Care

Service companies

Bayer Business Services

Bayer Technology

Services

Currenta

39% of Bayer Health

Care Revenue



Arne Stöcker


Structure

Bayer Schering

Pharma AG

Diagnostic Imaging

X-ray contrast media

Women´s Healthcare

Menopause management

Specialty Medicine

Drugs for solid tumor

therapy

Age related eye diseases

General Medicine

High blood pressure

Men´s Healthcare

Bacterial infection


Arne Stöcker


Locations

• Headquarter

– Berlin, Germany

• R&D

– Berlin, Wuppertal, Cologne, Leverkusen, Germany

– Berkley, CA, Montville, NJ, USA

– Osaka, Japan

– Peking, China

• Production

– Europe, USA, Asia


Arne Stöcker


Size (Capitalization, Employees)

• Employees

– > 36,000 world wide (Schering had 24,000)

• > 5,800 in R&D

• 100% Stockholder is the Bayer Schering GmbH

– A wholly owned subsidiary of the Bayer AG

• Bayer AG

– Business financing: 35% self

– Company value: ~ $60 billion

– Assets : ~ $24.7 billion


Source: dutypharmacy.com

Arne Stöcker


Top executives


Arne Stöcker


Partnerships

• Bausch & Lomb

– Selective receptor for treatment of eye diseases

• Johnson & Johnson

– Development of anticoagulant

• Pfizer

– Development of inhibitor for diabetes


Arne Stöcker


Outline





Arne Stöcker


Financial Report

• R&D expenditures ~$ 2,025 billion (2009)

Source: dpa

Financial Summary

2008 2009 Change

$ billion $ billion %

Revenue $13,541 $14,130 4.4%

EBIT $1,650 $2,290 38.8%

Arne Stöcker


Stock trend (Bayer AG)

Financial Summary

Arne Stöcker


Outline





Arne Stöcker


Products / Primary markets

Product Indication Business area Net sales(million)

Yasmin/ YAZ/ Yasminelle hormonal contraceptive Womes Healthcare $ 1,725

Betaferon/ Betaseron multiple sclerosis Specialty Medicine $ 1,639

Kogenate/ Helixate hemophilia Specialty Medicine $ 1,199

Adalat high blood pressure General Medicine $ 855

Nexavar kidney and liver cancer Specialty Medicine $ 815

Mirenahormonal intrauterine

delivery system for contraceptionWomes Healthcare $ 662

Avalox/ Avelox respiratory tract infections General Medicine $ 621

Levitradrug for treating erectile

dysfunctionGeneral Medicine $ 486

Cipro/ Ciprobay infectious diseases General Medicine $ 447

Glucobay Diabetes General Medicine $ 444

Scope of products

Arne Stöcker


Competitors

• Pfizer

• Bristol-Myers Squibb

• Merck KGaA (EMD)

• Teva Pharmaceutical Industries Ltd.

Scope of products

Arne Stöcker


Outline





Arne Stöcker


Current critical business issues

• 2000 - Death of seven teenagers in relation to “Yasmin”

• 2010 - Facing lawsuit in Germany because of pregnancy

test from 1970

• 2010 - Company announced to change the name to

Bayer HealthCare and drop the “Schering”

Cost and business issues

Arne Stöcker


Summary – Key facts

• Subsidiary of Bayer AG

• Founded 1851 (Schering) merged in 2006

– 36,000 Employees, ~$14 billion Revenue (2009)

• One of the ten largest manufacturers for specialty

medicine

• World market leader in development of contrast media

for X-ray

Summary

Arne Stöcker


Literature

• http://www.bayerhealthcare.com

• http://www.presse.bayer.de

• http://www.consumernewsweekly.com/

• http://www.bayerscheringpharma.de/en

• Bayer Schering Pharma Corporate Brochure May 2010

• Bayer AG Annual Report 2009

Arne Stöcker


Thank you for your attention

Questions?!


Documents

IE618 Company Profile Presentation Bayer Schering (Germany)caudill/Bayer.pdf · Arne Stöcker Denis Stoimenov Joachim Hacke Waldemar Seel Wan Mohd Norudin IE618 Company Profile Presentation